mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
0.003 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.41 |
0.004 |